Matches in SemOpenAlex for { <https://semopenalex.org/work/W2769545549> ?p ?o ?g. }
- W2769545549 endingPage "536" @default.
- W2769545549 startingPage "529" @default.
- W2769545549 abstract "We previously published results for 70 children who received conditioning with treosulfan and cyclophosphamide (n = 30) or fludarabine (n = 40) before undergoing hematopoietic stem cell transplantation (HSCT) for primary immunodeficiency (PID). Toxicity was lower and T cell chimerism was better in the patients receiving fludarabine, but cohort numbers were relatively small and follow-up was short. Here we report outcomes of 160 children who received homogeneous conditioning with treosulfan, fludarabine, and, in most cases, alemtuzumab (n = 124). The median age at transplantation was 1.36 years (range, .09 to 18.25 years). Donors included 73 matched unrelated, 54 1 to 3 antigen-mismatched unrelated, 12 matched sibling, 17 other matched family, and 4 haploidentical donors. Stem cell source was peripheral blood stem cells (PBSCs) in 70, bone marrow in 49, and cord blood in 41. Median duration of follow-up was 4.3 years (range, .8 to 9.4 years). Overall survival was 83%. No patients had veno-occlusive disease. Seventy-four patients (46%) had acute GVHD, but only 14 (9%) greater than grade II. Four patients underwent successful retransplantation for graft loss or poor immune reconstitution. Another patient experienced graft rejection and died. There was no association between T cell chimerism >95% and stem cell source, but a significant association was seen between myeloid chimerism >95% and use of PBSCs without an increased risk of significant GVHD compared with other sources. All 11 patients with severe combined immunodeficiency diagnosed at birth were alive at up to 8.7 years of follow-up. Long-term studies are needed to determine late gonadotoxic effects, and pharmacokinetic studies are needed to identify whether specific targeting is advantageous. The combination of treosulfan, fludarabine, and alemtuzumab is associated with excellent results in HSCT for PID." @default.
- W2769545549 created "2017-12-04" @default.
- W2769545549 creator A5009510239 @default.
- W2769545549 creator A5013983797 @default.
- W2769545549 creator A5014990865 @default.
- W2769545549 creator A5033734650 @default.
- W2769545549 creator A5039237185 @default.
- W2769545549 creator A5044799435 @default.
- W2769545549 creator A5052243411 @default.
- W2769545549 creator A5056892740 @default.
- W2769545549 creator A5061463272 @default.
- W2769545549 creator A5061478893 @default.
- W2769545549 creator A5072838648 @default.
- W2769545549 creator A5073776230 @default.
- W2769545549 creator A5074285851 @default.
- W2769545549 creator A5074733171 @default.
- W2769545549 creator A5083433718 @default.
- W2769545549 creator A5090229750 @default.
- W2769545549 creator A5090643085 @default.
- W2769545549 date "2018-03-01" @default.
- W2769545549 modified "2023-09-25" @default.
- W2769545549 title "Treosulfan and Fludarabine Conditioning for Hematopoietic Stem Cell Transplantation in Children with Primary Immunodeficiency: UK Experience" @default.
- W2769545549 cites W1194989569 @default.
- W2769545549 cites W1505906622 @default.
- W2769545549 cites W1559794160 @default.
- W2769545549 cites W1561447687 @default.
- W2769545549 cites W1587703129 @default.
- W2769545549 cites W1818576030 @default.
- W2769545549 cites W1905316647 @default.
- W2769545549 cites W1984044481 @default.
- W2769545549 cites W1984641455 @default.
- W2769545549 cites W1985550470 @default.
- W2769545549 cites W1993572527 @default.
- W2769545549 cites W2001235268 @default.
- W2769545549 cites W2008973770 @default.
- W2769545549 cites W2023241971 @default.
- W2769545549 cites W2033963009 @default.
- W2769545549 cites W2035056593 @default.
- W2769545549 cites W2037051255 @default.
- W2769545549 cites W2039694858 @default.
- W2769545549 cites W2042391266 @default.
- W2769545549 cites W2043862689 @default.
- W2769545549 cites W2051443179 @default.
- W2769545549 cites W2064194978 @default.
- W2769545549 cites W2070233046 @default.
- W2769545549 cites W2082236208 @default.
- W2769545549 cites W2086024031 @default.
- W2769545549 cites W2088882275 @default.
- W2769545549 cites W2090582369 @default.
- W2769545549 cites W2091936102 @default.
- W2769545549 cites W2100630425 @default.
- W2769545549 cites W2134614087 @default.
- W2769545549 cites W2136180824 @default.
- W2769545549 cites W2153229010 @default.
- W2769545549 cites W2160429342 @default.
- W2769545549 cites W2170677852 @default.
- W2769545549 cites W2291710263 @default.
- W2769545549 cites W2321937065 @default.
- W2769545549 cites W2328093288 @default.
- W2769545549 cites W2379365975 @default.
- W2769545549 cites W2403934281 @default.
- W2769545549 cites W2582896772 @default.
- W2769545549 cites W2592164063 @default.
- W2769545549 doi "https://doi.org/10.1016/j.bbmt.2017.11.009" @default.
- W2769545549 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29155317" @default.
- W2769545549 hasPublicationYear "2018" @default.
- W2769545549 type Work @default.
- W2769545549 sameAs 2769545549 @default.
- W2769545549 citedByCount "69" @default.
- W2769545549 countsByYear W27695455492018 @default.
- W2769545549 countsByYear W27695455492019 @default.
- W2769545549 countsByYear W27695455492020 @default.
- W2769545549 countsByYear W27695455492021 @default.
- W2769545549 countsByYear W27695455492022 @default.
- W2769545549 countsByYear W27695455492023 @default.
- W2769545549 crossrefType "journal-article" @default.
- W2769545549 hasAuthorship W2769545549A5009510239 @default.
- W2769545549 hasAuthorship W2769545549A5013983797 @default.
- W2769545549 hasAuthorship W2769545549A5014990865 @default.
- W2769545549 hasAuthorship W2769545549A5033734650 @default.
- W2769545549 hasAuthorship W2769545549A5039237185 @default.
- W2769545549 hasAuthorship W2769545549A5044799435 @default.
- W2769545549 hasAuthorship W2769545549A5052243411 @default.
- W2769545549 hasAuthorship W2769545549A5056892740 @default.
- W2769545549 hasAuthorship W2769545549A5061463272 @default.
- W2769545549 hasAuthorship W2769545549A5061478893 @default.
- W2769545549 hasAuthorship W2769545549A5072838648 @default.
- W2769545549 hasAuthorship W2769545549A5073776230 @default.
- W2769545549 hasAuthorship W2769545549A5074285851 @default.
- W2769545549 hasAuthorship W2769545549A5074733171 @default.
- W2769545549 hasAuthorship W2769545549A5083433718 @default.
- W2769545549 hasAuthorship W2769545549A5090229750 @default.
- W2769545549 hasAuthorship W2769545549A5090643085 @default.
- W2769545549 hasBestOaLocation W27695455491 @default.
- W2769545549 hasConcept C126322002 @default.
- W2769545549 hasConcept C141071460 @default.
- W2769545549 hasConcept C2776694085 @default.
- W2769545549 hasConcept C2776755627 @default.